sso farmakologi obat

33
Pharmacology N225B: Review, Spring 2008 UCLA School of Nursing Sophie Sokolow, PhD, MPHARM Factor 6-266

Upload: dinel-obed

Post on 11-Sep-2015

289 views

Category:

Documents


3 download

DESCRIPTION

tentang obat maag dan jantung

TRANSCRIPT

  • Pharmacology N225B: Review, Spring 2008Review, Spring 2008

    UCLA School of NursingSophie Sokolow, PhD, MPHARM

    Factor 6-266

  • Peripheral Nervous system

  • Anatomi para simpatis & simpatis

  • Peripheral nervous system

    Somatic motor systemConscious control ofmovement, respiration, postureFunction:

    Autonomic nervous systemInvoluntary control of visceral functions. Parasympathetic Sympathetic nervous systemsFunction:

    Control Skeletal muscle via neuromuscular junction

    Sympathetic nervous systems

    3 principal functions:1. Regulate Heart 2. Regulate Secretory glands (salivary, gastric, sweat, bronchial)

    3. Regulate Smooth muscles (bronchi, blood vessels, urogenital, GI)

  • Autonomous Nervous system

  • Anatomic considerations

    Figure 13-3 The basic anatomy of the parasympathetic and sympathetic nervous systems and the somatic motor system.

  • Locations of cholinergic and adrenergic receptor subtypes

    Figure 13-6

  • Neurotransmitters

    Norepinephrine(NA,

    adrenergic)

    Practically all SNS post-

    ganglionic neurons (except sweat

    Acetylcholine (Ach,

    cholinergic)

    All PNS pre-ganglionic

    neurons ganglionic neurons (except sweat

    glands)

    Epinephrine

    Released from Adrenal

    medulla

    neurons

    All PNS post-ganglionic

    neurons

    All SNS pre-ganglionic

    neurons

    Most SNS post-ganglionic

    neurons to sweat glands

    All motor neurons to skeletal

    muscles

  • Parasympathetic (PNS)/ Sympathetic nervous (SNS) systems

    PNS (Cholinergic)7 functions1. HR 2.gastric secretion

    SNS (Adrenergic)3 functions1. Regulating cardiovascular system 2.gastric secretion

    3.Emptying of bladder4.Emptying of bowel5.Focusing for near vision6.Constriction pupils (miosis)

    7.Bronchoconstriction

    system 2. Regulating body temperature3. Implementing fight-or-flight reaction

    HR and BPDilate pupils (mydriasis)Dilate bronchiMobilize stored energy

  • SNS vs. PNS functions

    CholinergicAdrenergic

  • Cholinergic drugs

    Direct cholinomimetics

  • Cholinergic Receptor subtypes

    Muscarinic receptors CNS PNS postganglionic endings

    Sweat glands

    Nicotinic receptors CNS Autonomic ganglia Neuromuscular junction Adrenal medulla Sweat glands Adrenal medulla

  • Cholinergic Drugs: direct cholinomimetics

    MOA: enhance transmission at cholinergic synapsesDrugs:Acetylcholine limited because of short duration ofactionMuscarinic agonistsMuscarinic agonists1.Muscarine: mushroom alkaloid used to discoversubtypes

    2.Bethanechol (Urecholine) Treatment of urinary retention Also increases GI motility

    3.Pilocarpine Glaucoma

  • Nicotine

    Natural liquid alkaloidMOA: Stimulates nicotinic receptors CNS and CV effectsDrugs:

    Varenicline (Chantix):Varenicline (Chantix): Nicotinic partial agonist for smoking cessation

  • Cholinergic Drugs

    Cholinesterases Inhibitors

  • Anticholinesterase drugs Indirect acting cholinomimetics

    MOA: inhibit the enzyme that degrades acetylcholineDrugs and Clinical uses:Reversible agents

    Edrophonium (Tensilon)

    Myasthenia Gravis

    Donepezil (Aricept), Tacrine (Cognex)

    Alzheimers disease

    Irreversible agentsEchothiophate (phospholine iodide)

    GlaucomaMalathion, sarin (nerve gas, no clinical use)

  • Anti-Cholinergic Drugs

    Muscarinic Antagonists

  • Anti-cholinergic drugs: Muscarinic Antagonists

    Agents:Atropine

    Clinical uses: Motion sickness

    MOA: Block muscarinic receptors

    AtropineScopolamine Ipratropium bromidePropantheline Trihexyphenidyl Benztropine...

    Motion sicknessAsthmaIncontinence (OAB)AntispasmodicBradyarrhythmiasAnti-parkinsonPreoperativeOpthalmology

  • Overactive Bladder (OAB) Therapy

    Anti-muscarinic agents:Nonselective (block M2 and M3 receptors)Tolterodine (Detrol); older

    M3 selective (block M3 receptors, most M3selective)selective)Oxybutynin (Ditropan)Solifenacin (Vesicare)Darifenacin (Enablex)

  • Anti-Cholinergic Drugs

    Neuromuscular blocking agents

  • Neuromuscular blocking agents

    MOA:Block nicotinic receptors at neuromuscular junctionNo CNS effects!Drugs and Clinical uses:Relaxation for surgical procedures, intubationRelaxation for surgical procedures, intubationNon-depolarizing:

    Tubocurarine, pancuronium bromide (Pavulon),vecuronium, cisatracurium

    Rapid hydrolysis by AChE; NM block lasts 5-10 min

    Depolarizing (persistent depolarization makes themuscle fiber resistant to further stimulation byACh)

    Succinylcholine (Anectine)

  • Botulinum toxin

    Produced by Clostridium botulinumMOA:Act pre-synaptically inhibit ACh release at the NMJ cause temporary local paralysis of injected muscleEffects last weeks to several monthsEffects last weeks to several monthsClinical Use:FDA Approved for limited disorders (i.e. strabismus, severe primary axillary hyperhidrosis, cervical dystonia)

    Worlwide 21 indications are approved for BotoxUnder FDA investigations for several disorders:

    Chronic migraineLimb Muscle pain, Back painOAB, etc.

    Cosmetic use: treat frown lines between the brows

  • Adrenergic Agonists

  • Beta1Heart

    Heart rate Force of contraction Velocity of conduction in

    Main Functions of Adrenergic Receptor Subtypes

    Alpha1Vasoconstriction

    Alpha2Located in presynaptic junction Velocity of conduction in

    AV nodeKidney

    Renin release

    Beta2Bronchial dilationRelaxation of uterine muscleVasodilationGlycogenolysis

    junctionMinimal clinical significance

    DopamineDilates renal blood vessels

  • Sympathomimetic drugs: catecholamines

    1.Epinephrine1 cardiac stimulation2 bronchodilation constriction of arterioles

    2.Isoproterenol (-selective)

    1 cardiac stimulation

    2 bronchodilation

    2.DobutaminearteriolesClinical Use: Acute hypersensitivity reactions

    Cardiac stimulant

    2.Dobutamine1 cardiac stimulation(some 1)

    Clinical Use: Increase contractility and cardiacoutput in hypotension and surgery

  • Sympathomimetic drugs: catecholamines (cont)

    4.Norepinephrine(Levophed)

    vasoconstriction1 cardiac stimulation

    5.Dopamine

    MOA:Stimulates dopamine receptors

    1 cardiac stimulation

    Clinical Use:Hypotension

    Stimulates dopamine receptors vasodilation of renal and mesenteric arteries

    Clinical Use:Hypotension and shock

  • Sympathomimetic drugs: Non-Catecholamines

    1.1.1.1. 2 selective agonists Terbutaline (Brethine) Albuterol (Proventil, Ventolin)

    Ritodrine

    2.2.2.2. 1 selective agonists Phenylephrine

    3.3.3.3. 2 selective agonists Clonidine (Catapres)

    Ritodrine

    4.Miscellaneous adrenergic agonists Amphetamine, Methylphenidate Ephedrine Phenylpropanolamine Cocaine

  • Adrenergic Antagonists

  • Adrenergic Receptor Antagonists1 selective antagonists

    Drugs and Clinical uses:HypertensionPrazosin (Minipres)Doxazosin (Cardura)Terazosin (Hytrin)

    Non selective antagonistsDrugs and Clinical uses: Pheochromocytoma

    PhenoxybenzamineTerazosin (Hytrin)

    Benign Prostatic Hypertrophy (BPH)Tamsulosin (Flomax)selective for prostate smoothmuscle vs. vascular smooth muscle

    Other agent used in BPH therapy:Finasteride (Propecia): has different MOA blocks 5- reductase blocks conversion of testosterone to dihydroxytestosterone

    PhenoxybenzaminePhentolamine

  • Adrenergic Receptor -Antagonists: : : : -blockers

    Nonselective 1 and 2Propranolol (Inderal)Nadolol (Corgard)

    Selective 1(cardioselective)

    Partial agonistsBlockers with intrinsic sympathomimetic activity (ISA)PindololAcebutolol: depress heart rate

    (cardioselective)Metoprolol (Lopressor) Atenolol (Tenormin)

    GlaucomaTimolol (timoptic)Carteolol (occupress) oral or drops

    Acebutolol: depress heart rateless than other -blockers

    Nonselective -blockade with blockadeLower BP without alterations in heart rate or cardiac outputLabetololCarvedilol

  • Adrenergic Receptor -Antagonists

    3.3.3.3. antagonists (-blockers)

    Clinical uses: Hypertension Angina Myocardial Infarction (MI) Myocardial Infarction (MI) Cardiac Heart Failure (CHF) Antiarrhythmics Migraine Pheochromocytoma Glaucoma

  • Respiratory Pharmacology

  • Drugs used in the treatment of COPD

    1. Bronchodilators short acting (as initial agents):a)Anti-cholinergics (ipratropium bromide), 1st linebronchodilatator alone or in combination with b.

    b)2-agonists (albuterol),

    2. Bronchodilators long acting (are added to 1.) :a) -agonists (salmoterol, formoterol),a) 2-agonists (salmoterol, formoterol),b)Anti-cholinergics (tiotropium bromide)c) Theophylline

    3. Corticosteroids ( of acute COPDexacerbations or chronically in severe patients):a)Oral (prednisone, prednisolone)b)Inhaled (fluticasone, beclomethasone, budesoinde), lessprominent role than in asthma

    4. Others (antibiotics, mucolytics, expectorants)